TY - JOUR
T1 - Teratogen-induced distortions in the classical NF-κB activation pathway
T2 - Correlation with the ability of embryos to survive teratogenic stress
AU - Molotski, Natali
AU - Savion, Shoshana
AU - Gerchikov, Natalie
AU - Fein, Amos
AU - Toder, Vladimir
AU - Torchinsky, Arkady
N1 - Funding Information:
This work was supported by Grant 6234-1 from the Israel Ministry of Health.
PY - 2008/6/1
Y1 - 2008/6/1
N2 - Studies with diverse teratogens implicated the transcription factor NF-κB in mechanisms determining teratological susceptibility of embryos. Here, a teratogen such as cyclophosphamide (CP) was used to test whether teratogenic insult alters the classical NF-κB activation pathway, and how these alterations correlate with the ability of mouse embryos to resist the teratogen-induced process of maldevelopment. We observed that embryos tested 24 h after the exposure of females to 40 mg/kg CP exhibited a dramatic decrease in the level of NF-κB (p65 subunit)-DNA binding, IκB kinase beta (IKKβ) activity, expression of p65 and IKKβ proteins, as well as NF-κB inhibitory proteins (IκBs) such as IκBα, IκBβ, and IκBε, and died within the next 24 h. Embryos of females exposed to 15 mg/kg CP exhibited only a decrease in NF-κB-DNA binding and IKKβ activity at 24 h. However, at 48 h, a more prominent decrease in NF-κB activity was observed, accompanied by a decreased expression of p65 and IKKβ proteins. These embryos died within the next 24 h. After treatment with 10 mg/kg CP, embryos survived until the end of the antenatal period of development, demonstrating a transient decrease in NF-κB-DNA binding activity and no alterations in NF-κB signaling. These results suggest that the classical NF-κB activation pathway may be among targets that teratogens engage to initiate abnormal development. Besides, the observation that embryos destined to be dead exhibited a dramatically decreased rate of cell proliferation suggests a pathway, whereby teratogen-induced alterations in NF-κB signaling may culminate in such a final effect as embryonic death.
AB - Studies with diverse teratogens implicated the transcription factor NF-κB in mechanisms determining teratological susceptibility of embryos. Here, a teratogen such as cyclophosphamide (CP) was used to test whether teratogenic insult alters the classical NF-κB activation pathway, and how these alterations correlate with the ability of mouse embryos to resist the teratogen-induced process of maldevelopment. We observed that embryos tested 24 h after the exposure of females to 40 mg/kg CP exhibited a dramatic decrease in the level of NF-κB (p65 subunit)-DNA binding, IκB kinase beta (IKKβ) activity, expression of p65 and IKKβ proteins, as well as NF-κB inhibitory proteins (IκBs) such as IκBα, IκBβ, and IκBε, and died within the next 24 h. Embryos of females exposed to 15 mg/kg CP exhibited only a decrease in NF-κB-DNA binding and IKKβ activity at 24 h. However, at 48 h, a more prominent decrease in NF-κB activity was observed, accompanied by a decreased expression of p65 and IKKβ proteins. These embryos died within the next 24 h. After treatment with 10 mg/kg CP, embryos survived until the end of the antenatal period of development, demonstrating a transient decrease in NF-κB-DNA binding activity and no alterations in NF-κB signaling. These results suggest that the classical NF-κB activation pathway may be among targets that teratogens engage to initiate abnormal development. Besides, the observation that embryos destined to be dead exhibited a dramatically decreased rate of cell proliferation suggests a pathway, whereby teratogen-induced alterations in NF-κB signaling may culminate in such a final effect as embryonic death.
KW - Embryo
KW - IKKβ
KW - IκBs
KW - NF-κB
KW - Teratogenesis
UR - http://www.scopus.com/inward/record.url?scp=43449087613&partnerID=8YFLogxK
U2 - 10.1016/j.taap.2008.01.011
DO - 10.1016/j.taap.2008.01.011
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 18395765
AN - SCOPUS:43449087613
SN - 0041-008X
VL - 229
SP - 197
EP - 205
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 2
ER -